Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition

Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition

• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is spreading globally. However, clinically effective antiviral treatments are not established. Favipiravir may prevent pneumonia and acute respiratory distress syndrome aggravation. We describe SARS-CoV-2-positive patients,...

Full description

Bibliographic Details
Main Authors: Hidenori Takahashi, Yoshinobu Iwasaki, Takayasu Watanabe, Naoki Ichinose, Yasusei Okada, Akito Oiwa, Takehiro Kobayashi, Mariko Moriya, Toshimi Oda
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
Viral pneumonia
Favipiravir
Acute respiratory distress syndrome
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220306779

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220306779

Similar Items